Hemogenyx Pharmaceuticals PLC
LSE:HEMO

Watchlist Manager
Hemogenyx Pharmaceuticals PLC Logo
Hemogenyx Pharmaceuticals PLC
LSE:HEMO
Watchlist
Price: 130.75 GBX -1.13%
Market Cap: 6m GBX

Wall Street
Price Targets

HEMO Price Targets Summary
Hemogenyx Pharmaceuticals PLC

There are no price targets for HEMO.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Hemogenyx Pharmaceuticals PLC Competitors:
Price Targets
1801
Innovent Biologics Inc
4% Downside
301047
Sino Biological Inc
10% Upside
BNTX
BioNTech SE
23% Upside
PEB
Pacific Edge Ltd
8% Downside
HPHA
Heidelberg Pharma AG
186% Upside
1167
Jacobio Pharmaceuticals Group Co Ltd
7% Downside
IMDX
Insight Molecular Diagnostics Inc
95% Upside
OSE
OSE Immunotherapeutics SA
237% Upside

Revenue
Forecast

Revenue Estimate
Hemogenyx Pharmaceuticals PLC

Revenue forecast
is not available for
Hemogenyx Pharmaceuticals PLC

Operating Income
Forecast

Operating Income Estimate
Hemogenyx Pharmaceuticals PLC

Operating Income forecast
is not available for
Hemogenyx Pharmaceuticals PLC

Net Income
Forecast

Net Income Estimate
Hemogenyx Pharmaceuticals PLC

Net Income forecast
is not available for
Hemogenyx Pharmaceuticals PLC
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HEMO's stock price target?
Not Available

HEMO doesn't have any price targets made by Wall Street professionals.

Back to Top